PPT-Massive Transfusion Protocol (

MTP vs Emergency Release of Blood Products at GW Similarities between MTP and emergency release Both are orders for the blood bank to immediately release blood products A typescreen or typecross is NOT needed to release blood products. 2. After completing this module staff will be able to:. Explain the purpose of the Code Crimson. Identify departments affected by Code Crimson. Identify criteria for calling a Code Crimson . Discuss patients at an increased risk for active . McNicol. Improves the patient’s own blood and avoids unnecessary transfusions. .. ‘THE THREE PILLARS’. Minimise blood loss. Optimise blood volume and red cell mass. Optimise patient’s tolerance of anaemia. Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction?. Jeannie Callum, BA, MD, FRCPC. Really?. Are we still talking. about this in 2017?. Disclosure. Determine volume and type of product, guided by clinical findings, estimated weight laboratory results and, if available, POC testing. Consult . haematologist. /transfusion specialist . as needed. Laboratory staff. Andrea Caballero, MD. January 15, 2015. LSU Journal Club. The . ProCESS. Investigators. N . Engl. J Med 2014; 370:1683-1693. May 1, 2014.. Background. . T. here are over 750,000 cases of severe sepsis and septic shock per year in the US. . .. ‘THE THREE PILLARS’. Minimise blood loss. Optimise blood volume and red cell mass. Optimise patient’s tolerance of anaemia. What is patient blood management?. Paradigm Shift. . 2001 Guidelines for . Massive transfusion protocol (MTPs) . Established to provide rapid blood replacement in a setting of severe . hemorrhage. Early optimal blood transfusion is essential to sustain organ perfusion and oxygenation. Tales from the Field. Judette M. Louis, MD, MPH. Associate Professor. Department of OB/GYN. Morsani College of Medicine and College of Public Health. University of South Florida. . Disclosure. I have no financial conflicts of interest to disclose . Infusion of . blood products . for the purpose of restoring circulating volume.. Administration . of blood and blood components requires knowledge of correct administration techniques and possible complications. Risk per . UNIT . Allergic. 3:100. Febrile . (. Leuko. -reduced Units). 1:100. TACO. 1:100. TRALI. 1:5,000. Sepsis. 1:5,000. Acute. hemolytic. 1:75,000. HBV. 1:160,000. HIV & HCV. 1:2. . million. Ordering Blood Products. Kathleen Madden MD. Department of Pathology. Objectives. Highlight key details about Type . and . Screen. Briefly discuss . indications . for blood product transfusions. Review UNMH policy on Emergency release RBCs. .” . . –Robert Beal, past director of International Federation of Red Cross. Transfusions: History. 1660s: First experiments in blood transfusion, transfused dog blood to humans. Patient died and experiments were banned.. Released October 2014 Table of ContentsIntroductionDevelopment of a Massive Transfusion Protocol: Engagement and ScopeTriggers for Initiating Massive TransfusionBlood Product Resuscitation in the Trau NOTIFICATION OF MASSIVE PROTOCOL. BLOOD TRANSFUSION SERVICE NOTIFICATION. Receive phone call from medical team member: Lab requires Patient name and Medical Record Number . BTS staff perform Patient History Search for completed testing .